Product Information
ETHOSUXIMIDE 250 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.2523 per EA under NDC 62135079012. Its NADAC has been published 116 times since Apr 10, 2024.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135079012
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200892On Market Since
9/9/2015
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG CAPSULE has been published 116 times since Apr 10, 2024, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2523 per EA |
|---|---|
| All-time high | $0.3509 (Apr 10, 2024) |
| All-time low | $0.1798 (Nov 20, 2024) |
| 52-week high | $0.2649 |
| 52-week low | $0.2210 |
| Median price | $0.2492 |
| Average price | $0.2490 |
| Largest weekly change | +67.2% (Aug 21, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.2523 per EA (NDC 62135079012), effective Jun 24, 2026.
How has the price of ETHOSUXIMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has declined 28.1%. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG CAPSULE?
Since Apr 10, 2024, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has ranged from a low of $0.1798 (Nov 20, 2024) to a high of $0.3509 (Apr 10, 2024), with a median of $0.2492 per EA.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ETHOSUXIMIDE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG CAPSULE?
ETHOSUXIMIDE 250 MG CAPSULE (NDC 62135079012) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification